2016 Flu Market Brief

  • ID: 3940352
  • Report
  • Region: United States
  • 18 Pages
  • Health Industry Distributors Association (HIDA)
1 of 4
Physician Offices Continue to be the Primary Site for Patient Vaccinations for both Adults (33.0%) and Children (63.7%)

Takeaways From The 2016 Flu Market Brief:

The 2016 HIDA Influenza Vaccine Production & Distribution Market Brief provides new insights into the flu products supply chain and key information from the sixth annual “HIDA Flu Products Survey” of distributors conducted in May 2016. The survey demonstrates the essential role that distributors will serve during the 2016-2017 flu season by helping healthcare facilities and patients access vaccines, hypodermic supplies, diagnostic tests, and more. 

The 2015-2016 influenza season occurred from October 4, 2015 - May 21, 2016. Flu activity was lower and peaked later compared to previous seasons, ultimately peaking in mid-March. Influenza A(H1N1)pdm09 viruses predominated overall, but influenza A(H3N2) viruses were common through December, while influenza B viruses were more commonly identified from mid-April through mid-May. The healthcare supply chain demonstrated flexibility and efficiency through 24-48 hour delivery and logistical expertise to ensure healthcare providers  were well-supplied throughout the flu season.

Additionally, the 2016 HIDA Influenza Vaccine Production & Distribution Market Brief provides key information on:

- Flu vaccine production, supply, and allocation
- Patient and physician vaccination trends
- Managing influenza with diagnostic resources
- Manufacturing and distribution processes
- 2016 Medicare reimbursements
- Quality reporting measures related to influenza vaccination
- Vaccine effectiveness trends.

Who Should Read This Report:

This report is intended for several key audiences: senior sales, marketing, and strategy executives of healthcare distribution and manufacturing companies, and healthcare sales staff in the field. Stakeholders in the influenza vaccine supply chain and government agencies responsible for the public health and oversight of the production and distribution of influenza vaccines will also find this report of interest.

READ MORE
Note: Product cover images may vary from those shown
2 of 4

1. Executive Summary

2. Manufacturers Predict 157-168 Million Doses Of Injectable Influenza Vaccine

3. Vaccine Choices For Patients, Providers 

4. 2015-2016 Flu Season Peaks In Mid-March

5. Flu Vaccine Effectiveness

6. Physician Offices Continue To Be Top Site For Vaccinations

7. Flu Products Survey Continues To Show Key Role Of Distributors

8. Flu Products Survey

9. 2016 Medicare Reimbursement Guide

10. Quality Reporting Requires Flu Vaccination Documentation 

11. Managing Influenza With Diagnostic Resources

12. Appendix: Distribution’s Role In Influenza Vaccination

List Of Figures:

- Influenza Vaccine Doses Distributed In The United States, By Season
- Influenza Vaccine Products For The 2016-2017 Influenza Season
- Total Doses Of Flu Vaccines Released By Week, 2015-2016
- 2015-2016 Seasonal Influenza Vaccine: Total Doses Distributed In Millions
- Adjusted Vaccine Effectiveness Estimates For Influenza Seasons From 2005-2016
- Place Of Flu Vaccination (%) For Children And Adults, National Immunization Survey–
- Flu And National Internet Flu Survey United States, Early 2015-2016 Flu Season
- Percentage Of Distributors Planning To Carry Flu-Related Product
- Units Of Flu-Related Product Delivered In 2015
- Percentage Of Total Flu-Related Product Delivered
- Number Of Reported Doses Delivered During The 2015-2016 Season Versus Number 
- Of Planned Doses To Be Distributed During The 2016-2017 Season
- Comparing Medicare Reimbursement For Flu Vaccines, 2014-2015 And 2015-2016
- Types Of Laboratory Based Tests
- What Do Providers Feel Are The Most Important Attributes Of RIDTs
- Influenza Vaccine Lot Release

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll